Ticker
$DHTI
1 catalyst touching DHTI in the last 60 days, newest first, each with the price move that followed.
- 62
DHTI settles disputed $1.16M credit facility claim for $20K
Dalrada's subsidiary Genefic agreed to settle a disputed claim from IBS funds for $20,000 on October 2, 2026. The settlement terminates all financing documents, releases all liens and guaranties (including CEO Brian Bonar's personal guaranty), and eliminates a contingent liability that IBS had asserted at $1.16M—removing legal and balance-sheet uncertainty.
DHTI ▲SEC 8-K · 7 Oct 2026, 12:00 UTC
Information only. AURA does not give buy or sell recommendations.